Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Summary Background Cognitive decline is a debilitating manifestation of disease progression in Parkinson’s disease. We aimed to develop a clinical-genetic score to predict global cognitive impairment in patients with the disease. Methods A prediction algorithm for global cognitive impairment (defined as Mini Mental State Exam (MMSE) ≤25) was built using data from 1,350 patients with 5,165 longitudinal visits over 12.8 (median, 2.8) years. Age at onset, MMSE, education, motor exam score, gender, depression and GBA mutations, machine selected through stepwise Cox’ hazards analysis and Akaike’s information criterion, were used to compute the multivariable predictor. Independent validation was achieved in another 1,132 patients with 19,127 visits over 8.6 (median, 6.5) years. Findings The cognitive risk score accurately predicted cognitive impairment within ten years of disease onset with an area under the curve (AUC) of >0.85 in both the discovery (95% CI, 0.821–0.902) and validation populations (95% CI, 0.779 – 0.913). 72.6% of patients scoring in the highest quartile were cognitively impaired by ten years vs. 3.7% in the lowest quartile (hazard ratio, 18.4, 95% CI, 9.4 – 36.1). Dementia or disabling cognitive impairment was predicted with an AUC of 0.877 (95% CI 0.788–0.943) and high negative predictive value (0.920, 95% 0.877–0.954) at the predefined cutoff (0.196). Performance was stable in 10,000 randomly resampled subsets. Interpretation Our predictive algorithm provides a potential test for future cognitive health or impairment in patients with Parkinson’s. It could improve trials of cognitive interventions and inform on prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
International Parkinson's Disease Genomics Consortium (IPDGC), Nalls, M. A., Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), Investigator, T. A. J. D., (CHARGE), C. F. H. A. A. R. I. G. E., North American Brain Expression Consortium (NABEC), et al. (2014) · Nature Genetics · doi:10.1038/ng.3043 · Cited by 1,895
Self-citationSeverity classification on the Hamilton depression rating scale
Zimmerman, M., Martinez, J. H., Young, D., Chelminski, I., & Dalrymple, K. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.04.028 · Cited by 1,199
Cognitive decline in Parkinson disease
Aarsland, D., Creese, B., Politis, M., Chaudhuri, K. R., ffytche, D. H., Weintraub, D., & Ballard, C. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.27 · Cited by 1,027
Risk of dementia in Parkinson’s disease: A community-based, prospective study
Aarsland, D., Andersen, K., Larsen, J. P., Lolk, A., Nielsen, H., & Kragh–Sørensen, P. (2001) · Neurology · doi:10.1212/wnl.56.6.730 · Cited by 721
Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest Study
Aarsland, D., Brønnick, K., Larsen, J. P., Tysnes, O. B., & Alves, G. (2009) · Neurology · doi:10.1212/01.wnl.0000338632.00552.cb · Cited by 625
Cited by
Bloem, B. R., Okun, M. S., & Klein, C. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00218-x · Cited by 3,920
Parkinson disease-associated cognitive impairment
Aarsland, D., Batzu, L., Halliday, G. M., Geurtsen, G. J., Ballard, C., Ray Chaudhuri, K., & Weintraub, D. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00280-3 · Cited by 1,371
The genetic architecture of Parkinson's disease
Blauwendraat, C., Nalls, M. A., & Singleton, A. B. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30287-x · Cited by 1,114
Sex differences in Alzheimer disease — the gateway to precision medicine
for the Women’s Brain Project and the Alzheimer Precision Medicine Initiative, Ferretti, M. T., Iulita, M. F., Cavedo, E., Chiesa, P. A., Schumacher Dimech, A., Santuccione Chadha, A., Baracchi, F., Girouard, H., Misoch, S., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0032-9 · Cited by 1,009
Designing stem-cell-based dopamine cell replacement trials for Parkinson’s disease
TRANSEURO consortium, & Barker, R. A. (2019) · Nature Medicine · doi:10.1038/s41591-019-0507-2 · Cited by 219
Self-citation
Metadata
- Authors
- Liu, G., Locascio, J. J., Corvol, J.-C., Boot, B., Liao, Z., Page, K., Franco, D., Burke, K., Jansen, I. E., Trisini-Lipsanopoulos, A., Winder-Rhodes, S., Tanner, C. M., Lang, A. E., Eberly, S., Elbaz, A., Brice, A., Mangone, G., Ravina, B., Shoulson, I., Cormier-Dequaire, F., Heutink, P., van Hilten, J. J., Barker, R. A., Williams-Gray, C. H., Marinus, J., Scherzer, C. R., Scherzer, C. R., Hyman, B. T., Ivinson, A. J., Trisini-Lipsanopoulos, A., Franco, D., Burke, K., Sudarsky, L. R., Hayes, M. T., Umeh, C. C., Sperling, R., Growdon, J. H., Schwarzschild, M. A., Hung, A. Y., Flaherty, A. W., Blacker, D., Wills, A.-M., Sohur, U. S., Mejia, N. I., Viswanathan, A., Gomperts, S. N., Khurana, V., Albers, M. W., Alora-Palli, M., McGinnis, S., Sharma, N., Dickerson, B., Frosch, M., Gomez-Isla, T., Greenberg, S., Gusella, J., Hedden, T., Hedley-Whyte, E. T., Koenig, A., Marquis-Sayagues, M., Marshall, G., Okereke, O., Stemmer-Rachaminov, A., Kloppenburg, J., Schlossmacher, M. G., Growdon, J. H., Selkoe, D. J., Sperling, R., Yi, T., Locascio, J. J., Li, H., Stalberg, G., Liao, Z., Barker, R., Foltynie, T., Williams-Gray, C., Robbins, T., Brayne, C., Mason, S., Winder-Rhodes, S., Barker, R., Williams-Gray, C., Breen, D. P., Cummins, G., Evans, J., Winder-Rhodes, S., van Hilten, J. J., Marinus, J., Corvol, J.-C., Brice, A., Corvol, J.-C., Elbaz, A., Mallet, A., Vidailhet, M., Bonnet, A.-M., Bonnet, C., Corvol, J.-C., Elbaz, A., Grabli, D., Hartmann, A., Klebe, S., Lacomblez, L., Mangone, G., Vidailhet, M., Bourdain, F., Brandel, J.-P., Derkinderen, P., Durif, F., Mesnage, V., Pico, F., Rascol, O., Brefel-Courbon, C., Ory-Magne, F., Forlani, S., Lesage, S., Mangone, G., Tahiri, K., Albin, R., Alcalay, R., Ascherio, A., Bowman, D., Chen-Plotkin, A., Dawson, T., Dewey, R., German, D., Saunders-Pullman, R., Scherzer, C., Vaillancourt, D., Petyuk, V., West, A., & Zhang, J.
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2017-08
- Volume
- 16
- Issue
- 8
- Pages
- 620-629
- ISSN
- 1474-4422 (ISSN-L)
- OpenAlex
- W2626981951
- Cited by
- 180
- References
- 6
- FWCI
- 11.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts. https://app.cochat.ai/papers/10.1016/s1474-4422(17)30122-9
- The paper
- Liu, G., Locascio, J. J., Corvol, J.-C., Boot, B., Liao, Z., Page, K., Franco, D., Burke, K., Jansen, I. E., Trisini-Lipsanopoulos, A., Winder-Rhodes, S., Tanner, C. M., Lang, A. E., Eberly, S., Elbaz, A., Brice, A., Mangone, G., Ravina, B., Shoulson, I., . . . Zhang, J. (2017). Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(17)30122-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.